丰原药业控股股东拟转让5.1%股份，不影响控制权

Core Viewpoint - Anhui Fengyuan Pharmaceutical Co., Ltd. announced the transfer of 23,698,554 shares, representing 5.10% of the total share capital, from its controlling shareholder Fengyuan Group to Hainan Guihe Dayi at a price of 6.72 CNY per share, totaling 159 million CNY [1] Group 1 - The transaction involves a share transfer that does not lead to a change in company control or affect governance and operations [1] - The buyer has committed to not reducing their stake within 18 months after the transfer [1] - The transaction is subject to compliance review by the Shenzhen Stock Exchange, introducing uncertainty regarding its final completion [1]